Important international contacts for the last 5 years
2016 – Professor of the Department Dobrova VE – participation in the conference International Research Project within the program “E-Education in Research Ethics: Central and Eastern Europe” with the support of the grant “Grant Number R25 TW007084 from the US National Institutes of Health (NIH) Fogarty International Center”, (Vilnius , Lithuania);
2017 – assistant Ratushna KL – training in “The Advanced Certificate Program in Research Ethics for Central and Eastern Europe” with the support of NIH Research Grant R25 TW7085 and the 13th International Conference for Clinical Ethics and Consultation (Singapore);
February-March 2017, a visiting professor of the associate professor of the department VV Propisnova was held. “Series of lectures at the Medical University of Varna under the ERASMUS + program”, (Varna, Bulgaria);
May 2017 – professors of the department Sakharov TS, Dobrova VE and associate professors Zupanets KO, Andreeva OO, Bezugla NP, Tarasenko OO, Shebeko SK – participation in the conference “The international conference on Pharmaceutical Drugs” (Dubai, UAE);
2017 – participation in the grant program of the assistant of the department Davishna NV from the European Association for Clinical Pharmacology and Therapeutics. and receiving a grant to travel and speak at the conference “Focus Meeting 2016” and participate in the international grant program “Fulbright Research and Development Program” (USA);
February 2018 – Head Department, Professor Zupanets IA and Associate Professors Shebeko SK and Zupanets KO – a trip to Innsbruck (Austria) to discuss research, exchange scientific experience, visit research laboratories of the University (Innsbruck, Austria) ;
April 2018 – Head Department, Professor Zupanets IA, Associate Professors Shebeko SK, Zupanets KO and Assistant Zhulai TS – participation in the international conference “27th Congress of the European Rhinologic Society, London Rhinology, Session CRS Medical Management” (London, UK);
April 2018 – Professor VE Dobrova – participation in the ISPOR Educational Webinar “Introduction to Basic Concepts of Health Technology Assessment”;
May 2018 – Professor Dobrova VE – internship within the international conference ISPOR 2018 (Baltimore, MD, USA);
July. August 2018 – Assistant Gerasimenko OV – internship under 87 EAS 2019 (Maastricht, Netherland) and participation in OMI seminars: Lipid Metabolism (Salzburg, Austria);
August 2018 – Professor Sakharova TS, Associate Professors Andreeva OO, Bezugla NP, Zupanets KO, Propisnova VV – participation in the World Congress on Bioavailability & Bioequivalence: BA / BE Studies Summit, (Tokyo, Japan, member of the organizing committee, head of the section – Assoc. Prof. Zupanets KO);
September 2018 visit of Werner Gilsdorf, Doctor of Science in Biology and State Expertise in Chemistry, international pharmacokinetic expert, accompanied by Ivan Loboda, Senior Technical Adviser on Drug Financing of the SAFEMed project. The event was held as part of the state project “Safe, Affordable and Effective Medicines for Ukrainians” (SAFEMed), in conjunction with the United States Agency for International Development (USAID). Employees of the department are involved in compiling the report “Technical report. SAFEMed: Safe, Affordable, and Effective Medicines for Ukrainians. Technical assistance for development of strategy on bioequivalence of medicines P YI Activity1.2.1. Review current Ukrainian and European Union legislation on bioequivalence in collaboration with the Ministry of Health »;
June 2019 – Assistant Ratushna KL – participation in a practical session on research ethics, organized by Clarkson University in conjunction with the Icahn School of Medicine at Mount Sinai (New York, USA) as part of a master’s program in bioethics at Clarkson University;
August 2019 – Professor Sakharov TS, Associate Professors Andreeva OO, Bezugla NP, Zupanets KO, Misyureva SV, Otrishko IA, Assistant Tkachenko KM – participation in the International Conference on Clinical ad Medical Case Reports (Zurich, Switzerland) and the International Conference on Pharmaceutical Drug Discovery and Advanced Drug Delivery Systems (Amsterdam, Neverland), member of the organizing committee, head of the section – Assoc. Zupanets KO);
March 2020 – Associate Professor KO Zupanets – internship at the M. Popp Institute (Innsbruck, Austria).
In 2020, when the WHO declared a pandemic in connection with the SARS-CoV-2 outbreak, the Department of Clinical Pharmacology and Clinical Pharmacy contributed to national measures to combat COVID-19 at the state level:
• Development of the Standard of pharmaceutical care “Coronavirus disease (COVID-19)”, approved by the Orders of the Ministry of Health of Ukraine № 663 from 13.03.2020 and №961 from 24.04.2020.
• • Methodological assistance to the structural units of the Office of the President of Ukraine for the organization of measures to combat COVID-19 (letter № 03-01 / 630 dated 21.04.2020). Professor Zupanets IA was appointed National Coordinator of the clinical study of drugs Corvitin and Kvertyn produced by PJSC NVC “Borschagivsky HFZ” in patients with pneumonia associated with 2019-nCoV acute respiratory disease, on the background of basic therapy.
• Development of informational and educational materials on the COVID-19 pandemic, which were published by the Ministry of Health of Ukraine and the All-Ukrainian Chamber of Pharmacy – prof. Zupanets IA, prof. Dobrova VE